Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Aitken-Saavedra J et al. | Diversity, frequency and antifungal resistance of Candida species in patients with type 2 diabetes mellitus. | 2018 | Acta Odontol. Scand. | pmid:30045641 |
| Nagai N et al. | Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles. | 2018 | Int J Mol Sci | pmid:30041452 |
| Monti D et al. | Influence of a Combination of Chemical Enhancers and Iontophoresis on In Vitro Transungual Permeation of Nystatin. | 2018 | AAPS PharmSciTech | pmid:29484614 |
| Lotan AM et al. | Topical Nystatin Treatment for Candida Infection Following Wound Reconstruction. | 2018 | Wounds | pmid:29481329 |
| Scheibler E et al. | Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans. | 2018 | Arch. Oral Biol. | pmid:29477025 |
| Neppelenbroek KH et al. | Effect of Incorporation of Antifungal Agents on the Ultimate Tensile Strength of Temporary Soft Denture Liners. | 2018 | J Prosthodont | pmid:29135059 |
| Wu SC et al. | Hyaluronan size alters chondrogenesis of adipose-derived stem cells via the CD44/ERK/SOX-9 pathway. | 2018 | Acta Biomater | pmid:29128538 |
| Bouallegui Y et al. | Effect of exposure time, particle size and uptake pathways in immune cell lysosomal cytotoxicity of mussels exposed to silver nanoparticles. | 2018 | Drug Chem Toxicol | pmid:28583008 |
| Kim HJ et al. | Antifungal Effect of a Dental Tissue Conditioner Containing Nystatin-Loaded Alginate Microparticles. | 2018 | J Nanosci Nanotechnol | pmid:29448504 |
| Yang JS et al. | Vibrio cholerae OmpU induces IL-8 expression in human intestinal epithelial cells. | 2018 | Mol. Immunol. | pmid:29145158 |
| Anwar A et al. | Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole. | 2018 | Parasitol. Res. | pmid:29218442 |
| Dawgul MA et al. | Activity of Diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside, its Hydrochloride, and N,N-dialkyl Derivatives Against Non-albicans Candida Isolates. | 2018 | Med Chem | pmid:29485003 |
| Atai Z et al. | In vivo study of antifungal effects of low-molecular-weight chitosan against Candida albicans. | 2017 | J Oral Sci | pmid:28904319 |
| Russo A et al. | Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation. | 2017 | Mycoses | pmid:28877374 |
| Scheibler E et al. | Use of nystatin and chlorhexidine in oral medicine: Properties, indications and pitfalls with focus on geriatric patients. | 2017 | Gerodontology | pmid:28556195 |
| Hotta J et al. | Intraoral Device for Optimal Antifungal Delivery in a Rat Model. | 2017 | Curr Drug Deliv | pmid:27739378 |
| Walmsley S et al. | Engineered biosynthesis and characterisation of disaccharide-modified 8-deoxyamphoteronolides. | 2017 | Appl. Microbiol. Biotechnol. | pmid:27858138 |
| Kinoshita H et al. | Anti-Rhodotorula activity of mycophenolic acid enhanced in the presence of polyene antibiotic nystatin. | 2017 | Lett. Appl. Microbiol. | pmid:27801509 |
| Peixoto LR et al. | Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp. | 2017 | Arch. Oral Biol. | pmid:27771586 |
| Mukherjee PK et al. | Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. | 2017 | AIDS | pmid:27677161 |